Trial
NCT03869684
A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Senju Pharmaceutical Co., Ltd.
Collaborators
PPD Development, LP
Condition
Age-related Macular Degeneration
Intervention
MT-0814
Why stopped
The study terminated for safety reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-20